Facing a breast cancer diagnosis is terrifying, and it is impossible to know how your illness may affect you and your family. Fortunately, extensive cancer research helps many survive cancer, and oncologists and researchers work hard to ensure that breast cancer patients receive the most up to date, appropriate medical treatment.
Often, patients receive medication designed to stop the growth of cancer in their bodies. Taxotere is one of the most commonly prescribed medications to treat breast cancer. While this drug has proven effective as a chemotherapy treatment, it can also cause permanent hair loss for some.
If you suffered permanent hair loss after receiving Taxotere as part of your chemotherapy, you should consider seeking compensation from the drug’s manufacturer, Sanofi-Aventis. A Taxotere lawyer can try to help you research and construct your claim from the ground. A skilled dangerous drugs attorney can assist you in trying to get the compensation you may be entitled to.
Taxotere and Breast Cancer Treatment
According to the Centers for Disease Control and Prevention (CDC), breast cancer is the most common cancer among women in the United States. The CDC also notes that chemotherapy is one of the most common treatments for breast cancer. Chemotherapy medications destroy cancer cells; as an oral pill or an intravenous medication. Taxotere is one of the more widely used chemotherapy medications for breast cancer patients.
What Role Do Taxotere Claims Play?
Experts recognize this drug as one of the most effective chemotherapy medication. However, as recent lawsuits filed against Sanofi-Aventis have made clear there are equally effective drugs available with less undesirable side effects. If someone has suffered permanent hair loss, they should call a Taxotere lawyer as soon as possible.
Cases of Hair Loss Caused by Taxotere Use
Though every medication has its side effects; drug manufacturers such as Sanofi-Aventis are responsible for ensuring their drugs do not cause significant harm to anyone taking them. One of the most devastating potential side effect of Taxotere is permanent hair loss. Many survivors endure the hardship of temporary hair loss when they undergo chemotherapy. Generally, breast cancer survivors can expect to regrow their hair within a few months after their treatment ends.
Understanding the Risk of Permanent Loss
Recent studies and investigations show that Taxotere can cause permanent hair loss, or alopecia, and that Sanofi-Aventis failed to properly warn an untold number of patients and their doctors about this also devastating side effect.
Sanofi-Aventis has a responsibility mandated by the FDA to warn patients and prescribers about the increased risk for alopecia. Unfortunately, they failed to do so in the case of Taxotere. Breast cancer survivors who now suffer permanent hair loss after chemotherapy should contact a Taxotere lawyer right away.